Valerie Mandriota Banner-Goodspeed, M.P.H.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Insufficiency | 7 | 2023 | 1199 | 0.800 |
Why?
|
Respiration, Artificial | 9 | 2023 | 2566 | 0.530 |
Why?
|
Cardiac Surgical Procedures | 7 | 2022 | 3526 | 0.440 |
Why?
|
Delirium | 5 | 2022 | 1608 | 0.410 |
Why?
|
Propofol | 4 | 2022 | 628 | 0.410 |
Why?
|
Survivors | 7 | 2023 | 2286 | 0.370 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 122 | 0.370 |
Why?
|
Critical Illness | 7 | 2022 | 2665 | 0.350 |
Why?
|
Anesthesia, Conduction | 2 | 2022 | 238 | 0.320 |
Why?
|
Positive-Pressure Respiration | 3 | 2021 | 632 | 0.310 |
Why?
|
Patient Discharge | 5 | 2023 | 3300 | 0.290 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2021 | 363 | 0.280 |
Why?
|
Lung Injury | 2 | 2022 | 436 | 0.270 |
Why?
|
Anesthetics, Inhalation | 2 | 2022 | 571 | 0.260 |
Why?
|
Intensive Care Units | 9 | 2023 | 3679 | 0.260 |
Why?
|
Hospital Mortality | 6 | 2022 | 5310 | 0.250 |
Why?
|
Heme | 2 | 2023 | 307 | 0.220 |
Why?
|
Neuromuscular Blockade | 2 | 2021 | 146 | 0.210 |
Why?
|
Survival | 1 | 2021 | 162 | 0.200 |
Why?
|
Methyl Ethers | 1 | 2022 | 205 | 0.190 |
Why?
|
Neutrophils | 2 | 2023 | 3711 | 0.180 |
Why?
|
Esophagus | 3 | 2021 | 1017 | 0.180 |
Why?
|
Oxygen | 3 | 2021 | 4169 | 0.170 |
Why?
|
Embolism, Paradoxical | 1 | 2019 | 58 | 0.170 |
Why?
|
Relaxation Therapy | 1 | 2019 | 178 | 0.160 |
Why?
|
Enoxaparin | 1 | 2021 | 377 | 0.160 |
Why?
|
Acetaminophen | 2 | 2021 | 544 | 0.160 |
Why?
|
Dissent and Disputes | 1 | 2019 | 138 | 0.160 |
Why?
|
Hypnotics and Sedatives | 3 | 2022 | 1158 | 0.160 |
Why?
|
Thrombosis | 2 | 2021 | 2966 | 0.150 |
Why?
|
Critical Care | 3 | 2023 | 2640 | 0.150 |
Why?
|
Health Services Misuse | 1 | 2019 | 243 | 0.150 |
Why?
|
Intraoperative Care | 1 | 2021 | 766 | 0.150 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 408 | 0.140 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 381 | 0.140 |
Why?
|
Respiration | 1 | 2023 | 1645 | 0.140 |
Why?
|
Virus Diseases | 1 | 2022 | 710 | 0.140 |
Why?
|
Cardiopulmonary Bypass | 2 | 2019 | 1066 | 0.140 |
Why?
|
Foramen Ovale, Patent | 1 | 2019 | 223 | 0.140 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 365 | 0.130 |
Why?
|
Adrenergic beta-Agonists | 1 | 2017 | 346 | 0.130 |
Why?
|
Hyperoxia | 1 | 2017 | 262 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 971 | 0.130 |
Why?
|
Quality of Life | 5 | 2023 | 12730 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1262 | 0.130 |
Why?
|
Professional-Family Relations | 1 | 2019 | 481 | 0.130 |
Why?
|
Cholecalciferol | 1 | 2019 | 537 | 0.120 |
Why?
|
Dexmedetomidine | 1 | 2019 | 315 | 0.120 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.120 |
Why?
|
Nurses | 1 | 2023 | 2459 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1389 | 0.110 |
Why?
|
Cognition | 3 | 2020 | 6722 | 0.110 |
Why?
|
Length of Stay | 6 | 2023 | 6294 | 0.110 |
Why?
|
Perioperative Care | 1 | 2020 | 997 | 0.110 |
Why?
|
Hospitalization | 5 | 2023 | 10232 | 0.100 |
Why?
|
Humans | 47 | 2023 | 742088 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 886 | 0.100 |
Why?
|
Adult | 23 | 2023 | 213712 | 0.100 |
Why?
|
Vitamins | 1 | 2019 | 1608 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2017 | 953 | 0.100 |
Why?
|
Aged | 20 | 2023 | 162944 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2021 | 9941 | 0.090 |
Why?
|
Double-Blind Method | 6 | 2021 | 12017 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2021 | 2266 | 0.090 |
Why?
|
Terminal Care | 1 | 2022 | 1688 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2117 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2495 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1331 | 0.090 |
Why?
|
Prospective Studies | 10 | 2023 | 53187 | 0.090 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2019 | 1288 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1967 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2400 | 0.080 |
Why?
|
Aspirin | 2 | 2022 | 3278 | 0.080 |
Why?
|
Middle Aged | 20 | 2022 | 213127 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2022 | 15244 | 0.080 |
Why?
|
Registries | 2 | 2022 | 8077 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2281 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1847 | 0.080 |
Why?
|
Anesthetics, Intravenous | 2 | 2022 | 417 | 0.080 |
Why?
|
Male | 24 | 2022 | 349538 | 0.080 |
Why?
|
Pandemics | 3 | 2022 | 8328 | 0.080 |
Why?
|
Boston | 4 | 2021 | 9305 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2276 | 0.070 |
Why?
|
Female | 23 | 2022 | 379592 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4030 | 0.070 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1661 | 0.070 |
Why?
|
Anticoagulants | 1 | 2021 | 4595 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3151 | 0.070 |
Why?
|
Anxiety | 1 | 2019 | 4279 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3839 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3258 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4554 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9144 | 0.060 |
Why?
|
Treatment Failure | 2 | 2020 | 2615 | 0.060 |
Why?
|
Cohort Studies | 6 | 2023 | 40450 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6483 | 0.060 |
Why?
|
Rwanda | 2 | 2016 | 704 | 0.060 |
Why?
|
Motivation | 2 | 2023 | 1968 | 0.060 |
Why?
|
Immersion | 1 | 2022 | 34 | 0.060 |
Why?
|
Toll-Like Receptor 9 | 1 | 2023 | 212 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.050 |
Why?
|
Neostigmine | 1 | 2020 | 69 | 0.050 |
Why?
|
Risk Factors | 7 | 2022 | 72145 | 0.050 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 2156 | 0.050 |
Why?
|
Tidal Volume | 1 | 2022 | 489 | 0.050 |
Why?
|
Prone Position | 1 | 2021 | 194 | 0.050 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2021 | 1348 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1459 | 0.050 |
Why?
|
Resuscitation Orders | 1 | 2022 | 267 | 0.050 |
Why?
|
Polypharmacy | 1 | 2022 | 294 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2021 | 62966 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2020 | 5062 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15530 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2023 | 77098 | 0.040 |
Why?
|
Time | 1 | 2021 | 530 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 258 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3937 | 0.040 |
Why?
|
Patient Positioning | 1 | 2021 | 322 | 0.040 |
Why?
|
Chemokines | 1 | 2022 | 954 | 0.040 |
Why?
|
Patient Readmission | 2 | 2023 | 3111 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 186 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 814 | 0.040 |
Why?
|
Partial Pressure | 1 | 2017 | 253 | 0.040 |
Why?
|
Oximetry | 1 | 2021 | 467 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2022 | 57683 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 643 | 0.040 |
Why?
|
Hand | 1 | 2022 | 882 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2030 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2021 | 976 | 0.040 |
Why?
|
Time Factors | 4 | 2020 | 40054 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1916 | 0.030 |
Why?
|
Stroke | 1 | 2019 | 9963 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2022 | 2970 | 0.030 |
Why?
|
Age Distribution | 1 | 2022 | 2900 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13921 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1835 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1203 | 0.030 |
Why?
|
Actins | 1 | 2023 | 2120 | 0.030 |
Why?
|
Social Perception | 1 | 2019 | 424 | 0.030 |
Why?
|
Lung | 3 | 2022 | 9826 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 425 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1126 | 0.030 |
Why?
|
United States | 5 | 2023 | 69693 | 0.030 |
Why?
|
Mental Recall | 1 | 2021 | 1205 | 0.030 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 3667 | 0.030 |
Why?
|
Incidence | 3 | 2019 | 20928 | 0.030 |
Why?
|
Hospitals, Public | 1 | 2016 | 207 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2039 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2017 | 1104 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2899 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2414 | 0.030 |
Why?
|
Age Factors | 2 | 2022 | 18355 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1369 | 0.030 |
Why?
|
Operating Rooms | 1 | 2019 | 813 | 0.030 |
Why?
|
Research Design | 2 | 2019 | 5979 | 0.030 |
Why?
|
Social Support | 1 | 2022 | 2117 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1129 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21719 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1638 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2680 | 0.030 |
Why?
|
Postoperative Care | 1 | 2019 | 1484 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.030 |
Why?
|
Demography | 1 | 2016 | 1650 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 24913 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4392 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2021 | 2732 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2924 | 0.020 |
Why?
|
Probability | 1 | 2016 | 2502 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4414 | 0.020 |
Why?
|
Attitude to Health | 1 | 2019 | 2051 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39004 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2680 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 85649 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56350 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9846 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6534 | 0.020 |
Why?
|
Sex Factors | 1 | 2022 | 10392 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3391 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10372 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2749 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3211 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2021 | 4369 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5295 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81045 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2997 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7901 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 7010 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12695 | 0.020 |
Why?
|
Poverty | 1 | 2016 | 2646 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7276 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3738 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9679 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14720 | 0.010 |
Why?
|
Developing Countries | 1 | 2016 | 2789 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5978 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5304 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5100 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168561 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12705 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 40955 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19862 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7645 | 0.010 |
Why?
|
Child | 1 | 2022 | 77478 | 0.010 |
Why?
|